Chronic Kidney Disease

Chronic kidney disease (CKD) is a long-term decline in kidney function, usually defined by a sustained reduction in estimated glomerular filtration rate (eGFR), persistent albumin in the urine, or other markers of kidney damage present for at least 3 months. The kidneys help regulate fluid balance, electrolytes, acid-base status, blood pressure, red blood cell production, and bone-mineral metabolism, so CKD can affect far more than filtration alone. Common drivers include diabetes, hypertension, glomerular disease, genetic disorders, autoimmune conditions, and prior kidney injury. Treatment plans often vary because CKD is a spectrum rather than a single uniform disease, and risk can differ substantially by stage, albuminuria, cause, symptoms, and cardiovascular burden.

In Western medicine, management often focuses on slowing progression, reducing albuminuria, controlling blood pressure and blood sugar, treating complications, and preparing for renal replacement therapy when needed. In Eastern and integrative frameworks, clinicians may also consider symptom burden, energy levels, digestion, sleep, edema, and quality of life, using approaches such as acupuncture, individualized herbal medicine, and therapeutic food practices. Research support is not equal across options: some interventions are strongly studied and form the backbone of standard care, while others are used traditionally or as adjuncts with more limited or mixed evidence. That difference in evidence matters especially in CKD, where kidney clearance, electrolyte shifts, herb-drug interactions, and delayed recognition of progression can carry real risks.